Delova Biotech: Funding, Investors & Team (Oct 2026)
Delova Biotech specializes in the field of pain treatment.
Delova Biotech has raised $88.6M across 1 funding round on record, the most recent a Series C of $88.6M announced in Jul 2026.
That round is above the $45M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Delova Biotech Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Delova Biotech Funding Rounds
Delova Biotech Investors
20 investors are recorded in total; the 5 named above are those the record identifies.
Delova Biotech Funding Compared to Other Biotechnology Startups
Delova Biotech's latest round of $88.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Delova Biotech in Biotechnology and Qixia
Companies Similar to Delova Biotech
Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of…
Omini develops a biosensor platform that allows the simultaneous detection of multiple biomarkers.
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Senza Research is a healthcare and research company that offers a platform for clinical research to help make…
Sudu Technology is a high-tech enterprise specializing in the research and development of general-purpose…
Haoxinqing is an online medical service platform focusing on the fields of mental psychology and chronic…
Leadsynbio is a leading supplier of APIs, Human & Animal Nutrition ingredients. Innovative synthetic biology…
Zhongke lon engages in manufacturing high-end medical devices such as proton therapy equipment.
MaxSense Technology is an autonomous driving and industrial operation optimization developer company.
Sleptay is an innovative biopharmaceutical company, developing next-generation therapies for central nervous…
Xunjie Guangyuan operates engages in the research and development of near-infrared spectroscopy analysis…
Juxie Intelligent is an intelligent technology company that specializes in the development and production of…
Delova Biotech Funding FAQs
What does Delova Biotech do?
Delova Biotech specializes in the field of pain treatment.
How much funding has Delova Biotech raised?
Delova Biotech has raised $88.6M across 1 round on record. The most recent is a Series C of $88.6M announced in Jul 2026.
When did Delova Biotech last raise funding?
Delova Biotech's most recent funding round on record is a Series C of $88.6M, announced in Jul 2026.
Who has invested in Delova Biotech?
Investors on record for Delova Biotech include Jiangsu State-owned Farms Biotechnology Fund, Jiangsu High Investment, Legend Capital, China Capital Management, RiverHead Capital. FundedIQ records 20 investors in total.
Where is Delova Biotech headquartered?
Delova Biotech is based in Qixia, China.
How many employees does Delova Biotech have?
Delova Biotech is in the 51-100 employee band.
When was Delova Biotech founded?
Delova Biotech was founded in 2017.
How does Delova Biotech's funding compare to other Biotechnology startups?
Delova Biotech's latest round of $88.6M is above the $45M median round size for Biotechnology companies on FundedIQ across 7 tracked companies over the last two years.
About FundedIQ's Delova Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Delova Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.